HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK FSA Admits It Could Have ‘Better Anticipated’ CBD Application Bottleneck

Executive Summary

In a report to a forthcoming board meeting, UK FSA policy head Rebecca Sudworth acknowledges that the agency could have “better anticipated” the surge in cannabidiol applications received just before the 31 March 2021 deadline.

You may also be interested in...



CBD Supplements Safety: EU Two Years Behind UK

When it comes to assessing the safety of CBD in foods, the EU appears to be lagging behind the UK. Food Standards Agency CEO Emily Miles has noted that EFSA recently reached the same conclusions as the UK’s Committee on Toxicity did two years ago: there are still evidence gaps relating to CBD as a food. This may reassure UK operators that with the FSA further along in the assessment process it will not follow EFSA in suspending CBD novel food applications - but as expert Greer Deal notes, it's too soon to say. 

UK CBD Industry Vexed As FSA Publishes Searchable Public List – A Year Late

The UK Food Standards Agency has published its much anticipated searchable, online CBD public list. But after a long wait, the list's publication has triggered a wave of anxiety and criticism from CBD firms and experts. 

CBD Supplements, Teas And Flowers Up To 0.3% THC Allowed In France, For Now

France's Ministry of Solidarity and Health published a decree allowing the commercial sale of cannabis sativa extracts with a maximum THC content up to 0.3%, but banning the sale of raw cannabis flowers and leaves to consumers in all their forms, thus elimating a booming CBD market for tea, for example. The ban, however, has been halted by France's highest administrative court on the basis that it is disproportionate. While the Conseil d’Etat makes its final decision, French bricks-and-mortar and online CBD retailers can continue selling low-THC cannabis flowers and leaves.

Related Content

Topics

Latest News
UsernamePublicRestriction

Register

RS152262

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel